Frank L. Porfido
Nessuna posizione attualmente
Storia della carriera di Frank L. Porfido
Precedenti posizioni note di Frank L. Porfido
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Director of Finance/CFO | 13/05/2021 | 16/09/2022 |
| UroGen Pharma, Inc. | Corporate Officer/Principal | 01/06/2019 | 01/05/2021 |
Formazione di Frank L. Porfido
| Fairleigh Dickinson University | Masters Business Admin |
| Pace University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
| UroGen Pharma, Inc. | Health Technology |
- Borsa valori
- Insiders
- Frank L. Porfido
- Esperienza
